Accelerating Cancer Expertise

Bringing the Leading Expertise along the entire Patient Lifecycle to all Clinicians.

Our Mission

MRI Screening can Provide Peace of Mind to Half the World's Population and their Families.

Radera's Mission is to eliminate Prostate Cancer by Partnering with Radiologists and Urologists around the world to bring the Latest in Artificial Intelligence to the entire Patient Lifecycle. 

Determining when and how to screen all men, detecting cancer at its earliest possible onset, continued monitoring, through personalized treatment.

AI-RADS

From Screening through Diagnosis to Treatment - We are Developing an AI-driven, Collaborative Platform that Profoundly Enhances Cancer Screening, Detection, Grading and Monitoring for GPs, Surgeons, Oncologists, Pathologists and Radiologists.

 

Automated AI-Powered MRI Analysis for Prostate Cancer Diagnosis.

97% Accuracy for Clinical Significance.

93% Accuracy for Lesion Classification.

 

Computer Vision using Aritficial Intelligence to analyze multiparametric MRI images can accurately detect clinically significant lesions and provide risk characterization of active surveillance patients.

 

Get in touch!
Name  
E-mail  
Subject  
Message  

Drop us a line.

Published by
Radera GmbH
Kreillerstr. 139
81825 Munich
Germany

 

Contact
Email: info@radera.ai

 

Website
https://www.radera.ai

 

Legal Form
GmbH (Gesellschaft mit beschränkter Haftung)

 

Managing Board
Nikolaus Knauer, Matthias Pollach

 

Commercial Register
München, HRB-Nr: 251368 Amtsgericht München

 

Competent Supervisory Authority
Regierung von Oberbayern